[Results of clinical trials with cephadrine in children].
D000293:Adolescent; D001424:Bacterial Infections / Q000188:drug therapy*; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000009:adverse effects / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D004341:Drug Evaluation; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004927:Escherichia coli Infections / Q000188:drug therapy; D006192:Haemophilus Infections / Q000188:drug therapy; D006406:Hematoma / Q000209:etiology; D006801:Humans; D007223:Infant; D007710:Klebsiella Infections / Q000188:drug therapy; D007964:Leukocytosis / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010019:Osteomyelitis / Q000188:drug therapy; D010031:Otitis / Q000188:drug therapy; D010612:Pharyngitis / Q000188:drug therapy; D011008:Pneumococcal Infections / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011512:Proteus Infections / Q000188:drug therapy; D011704:Pyelonephritis / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012852:Sinusitis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D002511:Cephalosporins; D003510:Cyclohexanes
Ergebnisse einer klinischen Prüfung von Cephradin bein Kinderen.